L. Settas

2.6k total citations · 1 hit paper
20 papers, 2.0k citations indexed

About

L. Settas is a scholar working on Surgery, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, L. Settas has authored 20 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Pathology and Forensic Medicine and 5 papers in Rheumatology. Recurrent topics in L. Settas's work include Rheumatoid Arthritis Research and Therapies (5 papers), Infectious Diseases and Tuberculosis (3 papers) and Tuberculosis Research and Epidemiology (2 papers). L. Settas is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (5 papers), Infectious Diseases and Tuberculosis (3 papers) and Tuberculosis Research and Epidemiology (2 papers). L. Settas collaborates with scholars based in Greece, United Kingdom and Netherlands. L. Settas's co-authors include Saeed Fatenejad, Ronald Pedersen, Lars Klareskog, Désirée van der Heijde, Joseph Wajdula, Marie Sanda, Andrew Gough, Michel Malaise, Emilio Martín Mola and Joachim R. Kalden and has published in prestigious journals such as The Lancet, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

L. Settas

20 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

2004 1.4k citations Lars Klareskog, Désirée van der Heijde et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Settas Greece	12	1.5k	678	434	283	226	20	2.0k
Jonathan S. Coblyn United States	21	1.2k 0.8×	466 0.7×	443 1.0×	368 1.3×	189 0.8×	34	2.1k
Scott W. Baumgartner United States	16	1.4k 0.9×	1.0k 1.5×	766 1.8×	232 0.8×	164 0.7×	18	2.5k
William Palmer United States	17	1.6k 1.1×	757 1.1×	360 0.8×	448 1.6×	219 1.0×	24	2.1k
Jacques Tébib France	25	1.3k 0.9×	386 0.6×	669 1.5×	246 0.9×	208 0.9×	91	2.3k
Martina Biggioggero Italy	23	1.1k 0.7×	362 0.5×	555 1.3×	205 0.7×	118 0.5×	69	1.7k
Katerina Chatzidionysiou Sweden	22	1.9k 1.3×	647 1.0×	660 1.5×	505 1.8×	349 1.5×	88	2.4k
Douglas Schlichting United States	22	2.1k 1.4×	1.1k 1.6×	576 1.3×	662 2.3×	258 1.1×	33	2.8k
Agnes L. Maier United States	14	636 0.4×	366 0.5×	283 0.7×	220 0.8×	124 0.5×	22	1.1k
Hubert van Hoogstraten United States	18	917 0.6×	516 0.8×	429 1.0×	200 0.7×	82 0.4×	60	1.4k
Piero Marson Italy	24	380 0.3×	418 0.6×	351 0.8×	152 0.5×	170 0.8×	101	1.4k

Countries citing papers authored by L. Settas

Since Specialization

Citations

This map shows the geographic impact of L. Settas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Settas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Settas more than expected).

Fields of papers citing papers by L. Settas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Settas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Settas. The network helps show where L. Settas may publish in the future.

Co-authorship network of co-authors of L. Settas

This figure shows the co-authorship network connecting the top 25 collaborators of L. Settas. A scholar is included among the top collaborators of L. Settas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Settas. L. Settas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laskari, Katerina, Panagiota Boura, Alexandros Garyfallos, et al.. (2016). FRI0497 The Interleukin-1 Inhibitor Canakinumab for Familial Mediterranean Fever: Long-Term Beneficial Effect in A Cohort of 14 Patients. Annals of the Rheumatic Diseases. 75. 618–619. 1 indexed citations

Dimitroulas, Theodoros, George Giannakoulas, Haralambos Karvounis, et al.. (2014). Micro- and Macrovascular Treatment Targets in Scleroderma Heart Disease. Current Pharmaceutical Design. 20(4). 536–544. 36 indexed citations

Moralidis, Efstratios, et al.. (2011). Radionuclide imaging with human polyclonal immunoglobulin (Tc-HIG) and bone scan in patients with rheumatoid arthritis and serum-negative polyarthritis.. PubMed. 15(1). 37–42. 4 indexed citations

Dimitroulas, Theodoros, et al.. (2010). Scleroderma Renal Crisis Accompanied by New-Onset Pulmonary Hypertension: An Acute Systemic Endothelial Injury? Case Report and Literature Review. Inflammation & Allergy - Drug Targets. 9(4). 313–318. 5 indexed citations

Gika, Helen, Filippos Michopoulos, Georgios Theodoridis, et al.. (2008). Determination of two COX-2 inhibitors in serum and synovial fluid of patients with inflammatory arthritis by ultra performance liquid chromatography–inductively coupled plasma mass spectroscopy and quadrupole time-of-flight mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 49(3). 579–586. 29 indexed citations

Settas, L., et al.. (2007). Reactivation of Pulmonary Tuberculosis in a Patient With Rheumatoid Arthritis During Treatment With IL-1 Receptor Antagonists (Anakinra). JCR Journal of Clinical Rheumatology. 13(4). 219–220. 40 indexed citations

Heijde, Désirée van der, Maxime Dougados, Pál Géher, et al.. (2006). Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases. 65(12). 1572–1577. 102 indexed citations

Kartsios, Charalambos, et al.. (2006). Reversible T-large granular lymphocyte expansion and neutropenia associated with adalimumab therapy. Rheumatology International. 27(2). 201–202. 12 indexed citations

Sichletidis, Lazaros, L. Settas, Dionisiοs Spyratos, Diamantis Chloros, & D. Patakas. (2006). Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis.. PubMed. 10(10). 1127–32. 145 indexed citations

10.

Settas, L., et al.. (2006). Fibromyalgia - New Concepts of Pathogenesis and Treatment. International Journal of Immunopathology and Pharmacology. 19(1). 5–10. 74 indexed citations

11.

Heijde, Désirée van der, Robert Landewé, Lars Klareskog, et al.. (2005). Presentation and analysis of data on radiographic outcome in clinical trials: Experience from the TEMPO study. Arthritis & Rheumatism. 52(1). 49–60. 76 indexed citations

12.

Settas, L., et al.. (2005). Multiple Myeloma Presenting as MPO-ANCA Associated Microscopic Polyangiitis. European Journal of Inflammation. 3(3). 153–156. 5 indexed citations

13.

Klareskog, Lars, Désirée van der Heijde, J Jäger, et al.. (2004). Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. The Lancet. 363(9410). 675–681. 1408 indexed citations breakdown →

14.

Heijde, D. van der, Andrew Gough, Joachim R. Kalden, et al.. (2004). 31. SWITCHING BIOLOGICS AFTER INITIAL ANTI-TUMOUR NECROSIS FACTOR-α FAILURE; SUCCESS WITH FURTHER TNF-α ANTAGONISM BUT FAILURE ON SUBSEQUENT INTERLEUKIN-1 RECEPTOR ANTAGONIST. 1 indexed citations

15.

Macfarlane, David G. & L. Settas. (1984). Acute psoriatric arthropathy precipitated by oxprenolol.. Annals of the Rheumatic Diseases. 43(1). 102–104. 9 indexed citations

16.

Tourkantonis, A., Anastasios N. Lasaridis, & L. Settas. (1984). Clinical Experience with Long-Term Nitrendipine Treatment in Essential Hypertension. Journal of Cardiovascular Pharmacology. 6(Supplement 7). S1096–S1096. 11 indexed citations

17.

Lewis, David A. & L. Settas. (1983). Kingella kingae causing septic arthritis in Felty’s syndrome. Postgraduate Medical Journal. 59(694). 525–526. 13 indexed citations

18.

Dieppe, Paul, et al.. (1983). REMISSION OF PSEUDO-SPONDYLITIS WITH TREATMENT OF WHIPPLE'S DISEASE. Lara D. Veeken. 22(3). 181–182. 4 indexed citations

19.

Settas, L., Michael Doherty, & Paul Dieppe. (1982). Localised chondrocalcinosis in unstable joints.. BMJ. 285(6336). 175–176. 17 indexed citations

20.

Settas, L., et al.. (1981). Haemodialysis and Hypothalamo-Pituitary-Testicular Axis. The Nephron journals/Nephron journals. 27(4-5). 271–272. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact